24Serious

Luke Jackson

Luke Jackson

Ask VT AI

View News Summary

Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
Thailand and Cambodia sign ceasefire at ASEAN summit, brokered by U.S. President Trump, but face challenges in implementation.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
Thailand and Cambodia sign ceasefire at ASEAN summit, brokered by U.S. President Trump, but face challenges in implementation.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Luke Jackson